Specificity of Gibberellin and Sucrose-promoted Flower Bud Growth in Gladiolus

A critical stage in flower bud growth in the spike of Gladioluswhich is initiated by gibberellic acid (GA₃) and sustained bysucrose has been identified. This corresponds to the stage atwhich separation of the outer bract occurs. In buds at differentdevelopmental stages isolated and held in water, it is the samebud stage that first shows increased growth. Buds not inducedby light were shown to respond more significantly to GA₃ andsucrose than those induced by light. Since the separation ofthe outer bract results in light-induced amylase productionand starch hydrolysis leading to petal growth, it is proposedthat growth promotion by GA₃ is related to light-induced petalgrowth at this specific stage. flower bud growth, Gladiolus natalensis, gibberellic acid, sucrose     

A Clinical Trial to Evaluate the Efficacy of α-Viniferin in Staphylococcus aureus – Specific Decolonization without Depleting the Normal Microbiota of Nares

Staphylococcus aureus is currently a significant multidrug-resistant bacterium, causing severe healthcare-associated and community-acquired infections worldwide. The current antibiotic regimen against this pathogen is becoming ineffective due to resistance, in addition, they disrupt the normal microbiota. It highlights the urgent need for a pathogen-specific drug with high antibacterial efficacy against S. aureus. α-Viniferin, a bioactive phytochemical compound, has been reported to have excellent anti-Staphylococcus efficacy as a topical agent. However, so far, there were no clinical trials that have been conducted to elucidate its efficacy. The present study aimed to investigate the antibacterial efficacy of α-viniferin against S. aureus in a ten-day clinical trial. Based on the results, α-viniferin showed 50% minimum inhibitory concentrations (MIC₅₀ values) of 7.8 μg/ml in culture broth medium. α-Viniferin was administered in the nares three times a day for ten days using a sterile cotton swab stick. Nasal swab specimens were collected before (0 days) and after finishing the trial (10^th day), and then analyzed. In the culture and RT-PCR-based analysis, S. ureus was reduced significantly: 0.01. In addition, 16S ribosomal RNA-based amplicon sequencing analysis showed that S. aureus reduced from 51.03% to 23.99% at the genus level. RNA-seq analysis was also done to gain insights into molecular mechanisms of α-viniferin against S. aureus, which revealed that some gene groups were reduced in 5-fold FC cutoff at two times MIC conditions. The study results demonstrate α-viniferin as a potential S. aureus-specific drug candidate.